| GSTM2 |
Detoxification of toxins and products of oxidative stress |
3.739 (q=0.0228) |
CELP |
— |
−6.476 (q=0.0029) |
| CYP1B1 |
Catalysation of metabolites |
3.535 (q=0.0002) |
GRAMD2 |
— |
−5.865 (q=0.0025) |
| ANXA1 |
Inhibits activation of NFKB |
3.489 (q=0.0074) |
CHP2 |
Regulation of cell proliferation and tumour growth |
−5.160 (q=0.0086) |
| ABI3BP |
Glycosaminoglycan binding |
2.561 (q=0.0037) |
CDHR1 |
Calcium-dependent cell adhesion molecule |
−5.123 (q=0.0020) |
| DES |
Regulation of sarcomere composition |
3.311 (q=0.0005) |
LRRC31 |
Regulates apoptosis and NFKB activation |
−5.104 (q=0.0006) |
| ABCA6 |
Regulates ATPase activity |
3.240 (q=0.0101) |
ISM2 |
Involved in complement pathway |
−4.753 (q=0.0375) |
| NAV3 |
Contributes to growth, differentiation and apoptosis |
3.209 (q=0.0351) |
KLHL32 |
Involved in protin ubiquitination |
−4.668 (q=0.0422) |
| ADAMTS1 |
Interacts with VEGFA |
1.839 (q=0.0438) |
SLC19A3 |
Transmembrane receptor |
−4.495 (q=0.0289) |
| ADAMTS9 |
Organ shape during development and angiogenesis |
2.255 (q=0.0098) |
C10orf99 |
— |
−4.442 (q<0.0001) |
| HDAC9 |
Regulates histone deacetylation |
3.061 (q=0.0385) |
NXPE4 |
— |
−4.372 (q=0.0438) |
